Outcomes in patients of pulmonary tuberculosis treated under RNTCP & follow up after 6 months

---

Original Article

Author Details : Sonisha Gupta*, Ankur Porwal, Atul Kumar Gupta

Volume : 8, Issue : 4, Year : 2021

Article Page : 196-201

https://doi.org/10.18231/j.jchm.2021.042

Suggest article by email

Get Permission

---

Abstract

Background: Tuberculosis (TB) is, one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent.
Materials and Methods: This Prospective study was conducted at Santosh medical college Ghaziabad from 1 April 2018 to 30 September 2019. All diagnosed PTB patients above 12yrs were taken. Patients with EPTB, HIV positive, MDR TB, XDR TB were excluded from the study. At the end of study treatment outcome was evaluated.
Results: Total of 208 patients diagnosed as tuberculosis were enrolled in the study. 6 patients died during course of study, 10 were treatment failure, 4 were lost to follow-up, 3 transferred out & 1 shifted to private treatment. 184 patients completed treatment successfully. Out of 184, only 152 patients were available for interview at 6 months follow up after completion of treatment. 19 could not be traced, 11 patients refused and 2 died. Out of 152, 110 were asymptomatic, 1 relapsed & rest 41 patients were symptomatic. All symptomatic patients were subjected to Chest X-Ray. Fibrosis was seen on CXR of 30 patients, bronchiectasis was seen in 3 patients, 1 patient had destroyed lung, nothing abnormal detected in 7 patients.
Conclusion: Even after successful treatment under RNTCP, these patients need to be followed up as many of them relapse or suffer from sequelae of tuberculosis.

Keywords: Outcomes, RNTCP, Pulmonary Tuberculosis, Follow­up, Fibrosis, Post­ Tubercular Chest x­ray, DOTS, Treatment Completion

How to cite : Gupta S, Porwal A, Gupta A K, Outcomes in patients of pulmonary tuberculosis treated under RNTCP & follow up after 6 months. J Community Health Manag 2021;8(4):196-201

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.